Skip to main content
Signal8

Sullivan Lara

SEC insider (Form 3/4/5 filer). CIK 0001769457. Chief Executive Officer at Pyxis Oncology, Inc. (PYXS). 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2025. Located in BOSTON, MA.

Companies Sullivan Lara has filed insider reports for

  • Pyxis Oncology, Inc. (PYXS): Director, Officer, Chief Executive Officer
Sullivan Lara profile photo

Sullivan Lara

CIK: 0001769457

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Pyxis Oncology, Inc. logo
PYXS

Pyxis Oncology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Mar 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    918.3K shares at avg. $0.98-
  • Pyxis Oncology, Inc. logo
    PYXS

    Pyxis Oncology, Inc.

    Dec 23, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    1.1M shares-

1-2 of 2